DrugPatentWatch Database Preview

Details for Patent: 8,309,122

« Back to Dashboard

Which drugs does patent 8,309,122 protect, and when does it expire?

Patent 8,309,122 protects OPANA ER and is included in one NDA.

This patent has forty-eight patent family members in sixteen countries.

Summary for Patent: 8,309,122

Title:	Oxymorphone controlled release formulations
Abstract:	The invention pertains to a method of relieving pain by administering a controlled release pharmaceutical tablet containing oxymorphone which produces a mean minimum blood plasma level 12 to 24 hours after dosing, as well as the tablet producing the sustained pain relief.
Inventor(s):	Kao; Huai-Hung (Syosset, NY), Baichwal; Anand R. (Wappingers Falls, NY), McCall; Troy (Smyma, GA), Lee; David (Chadds Ford, PA)
Assignee:	Endo Pharmaceuticals Inc. (Chadds Ford, PA)
Application Number:	11/680,432
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,309,122
Patent Claim Types: see list of patent claims	Composition; Formulation; Dosage form; Delivery; Use;

Drugs Protected by US Patent 8,309,122

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Endo Pharms	OPANA ER	oxymorphone hydrochloride	TABLET, EXTENDED RELEASE;ORAL	201655-001	Dec 9, 2011		DISCN	Yes	No			Y
Endo Pharms	OPANA ER	oxymorphone hydrochloride	TABLET, EXTENDED RELEASE;ORAL	201655-002	Dec 9, 2011		DISCN	Yes	No			Y
Endo Pharms	OPANA ER	oxymorphone hydrochloride	TABLET, EXTENDED RELEASE;ORAL	201655-003	Dec 9, 2011		DISCN	Yes	No			Y
Endo Pharms	OPANA ER	oxymorphone hydrochloride	TABLET, EXTENDED RELEASE;ORAL	201655-004	Dec 9, 2011		DISCN	Yes	No			Y
Endo Pharms	OPANA ER	oxymorphone hydrochloride	TABLET, EXTENDED RELEASE;ORAL	201655-005	Dec 9, 2011		DISCN	Yes	No			Y
Endo Pharms	OPANA ER	oxymorphone hydrochloride	TABLET, EXTENDED RELEASE;ORAL	201655-006	Dec 9, 2011		DISCN	Yes	No			Y
Endo Pharms	OPANA ER	oxymorphone hydrochloride	TABLET, EXTENDED RELEASE;ORAL	201655-007	Dec 9, 2011		DISCN	Yes	No			Y

International Family Members for US Patent 8,309,122

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	359077
Austria	376832
Australia	2002316582
Australia	2002318211
Australia	2002320309
Brazil	0205721
Brazil	0205722